High-mix insulins.

Indian J Endocrinol Metab

Tawam Medical Campus, Johns Hopkins Medicine, Dubai, United Arab Emirates ; Faculty of Medicine, UAE University, Al Ain, Abu Dhabi, United Arab Emirates.

Published: October 2015

Premix insulins are commonly used insulin preparations, which are available in varying ratios of different molecules. These drugs contain one short- or rapid-acting, and one intermediate- or long-acting insulin. High-mix insulins are mixtures of insulins that contain 50% or more than 50% of short-acting insulin. This review describes the clinical pharmacology of high-mix insulins, including data from randomized controlled trials. It suggests various ways, in which high-mix insulin can be used, including once daily, twice daily, thrice daily, hetero-mix, and reverse regimes. The authors provide a rational framework to help diabetes care professionals, identify indications for pragmatic high-mix use.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566356PMC
http://dx.doi.org/10.4103/2230-8210.163214DOI Listing

Publication Analysis

Top Keywords

high-mix insulins
12
high-mix
5
insulins premix
4
insulins
4
premix insulins
4
insulins commonly
4
insulin
4
commonly insulin
4
insulin preparations
4
preparations varying
4

Similar Publications

IMPACT India: Insights for Insulin Therapy in Routine Clinical Practice.

J Assoc Physicians India

April 2019

Departmentof Endocrinology, Bharti Hospital Karnal, Karnal, Haryana; *Corresponding Author.

Objective: Widely used in the management of diabetes, insulin therapy is influenced by several patient preferences and physician choices. This article reports the findings of the IMPACT survey, designed to assess insights on various factors which influence the choice of insulin therapy in India.

Methods: We administered a questionnaire which focused on the practice and patient profiles and the preferred regimens in specific clinical situations using a case scenario.

View Article and Find Full Text PDF

Introduction: Patients with type 2 diabetes, who live in Asian countries, often use premixed insulin analogs. However, if these solutions are insufficiently mixed prior to use, patients will receive inaccurate doses of intermediate- and/or short-acting insulin, which could affect diabetes control. This study aimed to determine whether insulin users were correctly resuspending premixed insulin analog solutions prior to use.

View Article and Find Full Text PDF

High-mix insulins.

Indian J Endocrinol Metab

October 2015

Tawam Medical Campus, Johns Hopkins Medicine, Dubai, United Arab Emirates ; Faculty of Medicine, UAE University, Al Ain, Abu Dhabi, United Arab Emirates.

Premix insulins are commonly used insulin preparations, which are available in varying ratios of different molecules. These drugs contain one short- or rapid-acting, and one intermediate- or long-acting insulin. High-mix insulins are mixtures of insulins that contain 50% or more than 50% of short-acting insulin.

View Article and Find Full Text PDF

Objective: To compare blood glucose control when using biphasic insulin aspart (BIAsp) three times a day (using 70/30 high-mix before breakfast and lunch), with biphasic human insulin (BHI, 30/70) twice daily in adults with type 2 diabetes already treated with insulin.

Research Design And Methods: In a 60-day, open-label, crossover study, people with insulin-treated type 2 diabetes [n = 38, baseline haemoglobin A1c 8.3 +/- 0.

View Article and Find Full Text PDF

Aim: To evaluate clinical efficacy and safety of biphasic insulin aspart (BIAsp) 30 twice daily (b.i.d.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!